The Targeted Agent and Profiling Utilization Registry (TAPUR) study is ASCO’s first clinical trial. In this podcast, ASCO Chief Medical Officer Dr. Richard Schilsky discusses TAPUR and why it is important to patients and the medical community. Read More >>
In the first Research Round Up podcasts of the summer, Charles Loprinzi, MD, and Kavitha Ramchandran, MD, discuss new research from the ASCO Annual Meeting on managing side effects and improving quality of life. Read More >>
ASCO's toll-free patient information line: 571-483-1780 or 888-651-3038
Cancer.Net provides timely, comprehensive, oncologist-approved information from the American Society of Clinical Oncology (ASCO), with support from the Conquer Cancer Foundation. Cancer.Net brings the expertise and resources of ASCO to people living with cancer and those who care for and about them to help patients and families make informed health care decisions.